UBS Reports Clorox Fiscal Q1 Organic Sales Growth Expected to Remain Under Pressure
UBS analysts indicate that The Clorox Company faces continued pressure on organic sales growth in the first fiscal quarter, with rising costs impacting earnings.
Stocks · News reference
JP Morgan Maintains Underweight on Clorox, Lowers Price Target to $83
JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $95 to $83.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
General Mills, Altria and Clorox offer high dividend yields, with analysts providing mixed ratings and updated price targets.
Morgan Stanley Maintains Equal-Weight on Clorox, Lowers Price Target to $87